#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Metabolic disorder Hypocalcaemia Severe myoclonic epilepsy of infancy Mantle cell lymphoma recurrent Acute hepatic failure Aicardi-Goutieres syndrome Infantile apnoea Chorioretinitis Malignant peritoneal neoplasm Fontan procedure Autoimmune demyelinating disease Allogenic stem cell transplantation Small intestine leiomyosarcoma Becker's muscular dystrophy Mantle cell lymphoma stage III More trials…

    Learn about Rare Diseases

    Cytokine release syndrome – Basic Information Friedreich’s ataxia – Life with Disease Medulloblastoma recurrent – Treatment Choroid melanoma – Trials in Disease Leiomyosarcoma metastatic – Diagnostics Hereditary ataxia – Treatment Piriformis syndrome – Diagnostics Chronic granulomatous disease – Treatment Acute respiratory distress syndrome – Life with Disease Inclusion body myositis – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Dacarbazine Etanercept [18F]Mc225 Tedizolid Phosphate Holcus Lanatus Pollen Extract Morphine Sulfate Tub-040 OSIMERTINIB MESYLATE Troriluzole POTASSIUM CLAVULANATE Glycine Mps-112 Siltuximab GS-4321 Febuxostat Hemihydrate Venglustat HYDROXYCHLOROQUINE 12 Grass Pollen Mixture Ht-29-B Poloxamer 407 More therapies…

    Learn about Your Condition

    Somatic symptom disorder Anal squamous cell carcinoma Dilated cardiomyopathy Tardive dyskinesia High-grade B-cell lymphoma Mitral valve incompetence Hepatic cirrhosis Meningorrhagia Pancreatic carcinoma Bacterial prostatitis Asthmatic crisis Skin ulcer Psychological trauma Multiple sclerosis Anxiety disorder More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hemic and Lymphatic Diseases

  • Evaluation of Enoxaparin for Prevention of Localized Intravascular Coagulopathy in Children with Slow-Flow Vascular Malformations Undergoing Interventional Procedures

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Vascular malformation
    Investigated Drugs:
    • Enoxaparin Sodium
    Spain

  • Study Comparing Golcadomide and Rituximab with Other Treatments for Patients with Relapsed or Refractory Follicular Lymphoma

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Follicular lymphoma
    Investigated Drugs:
    • Bendamustine Hydrochloride
    • Betamethasone Sodium Phosphate
    • Cyclophosphamide
    Finland France Germany Greece Italy The Netherlands +2

  • Evaluating Morphine Effectiveness Based on Kidney Function in Patients with Sickle Cell Disease During Vaso-occlusive Crisis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Sickle cell anaemia
    Investigated Drugs:
    • Morphine Hydrochloride
    • Iohexol
    France

  • Study on the Effectiveness and Safety of Pirtobrutinib and Rituximab for Untreated Adult Patients with Indolent Mantle Cell Lymphoma

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Pirtobrutinib
    • Rituximab
    Portugal Spain

  • Study of Acalabrutinib with R-CHOP for Patients with Untreated Mantle Cell Lymphoma in Spain

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Mantle cell lymphoma
    Investigated Drugs:
    • Acalabrutinib
    Spain

  • Study Comparing High-Dose and Standard-Dose Inactivated Influenza Vaccines in Adults with Blood Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Haematological malignancy
    Investigated Drugs:
    • A/DARWIN/9/2021 (H3N2) – LIKE STRAIN (A/DARWIN/6/2021, IVR-227)
    • INFLUENZA VIRUS A/DARWIN/9/2021 IVR-228 (H3N2)
    • Influenza Virus B/Michigan/01/2021
    Belgium
Previous Page
1 … 6 7 8 9 10 … 89
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!